Overall, the literature indicates that differences in neurocognitive status between IDH1 subgroups may reflect the differences in neuroplasticity, that is, the brain’s ability to adapt to a tumor, with IDH1-wt gliomas to allow a limited one. The gene discussed is IDH1; the disease is central nervous system cancer.